Evaluation of Border Entry Screening for Infectious Diseases in Humans

Selvey, Linda A.; Antao, Catarina; Hall, Robert

doi:10.3201/eid2102.131610

Cited by 53 publications

(51 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This allows the viruses to rapidly spread across continents, and efforts at airport screening to halt them have been fairly ineffective and costly. 5,6 This is in addition to the potential for in-flight transmission of the virus among passengers that was observed with SARS. 7 Once the pathogen has landed in a new country, the likelihood of contagion and spread is dependent on local transmission pathways and the strength of local health protection systems.…”

Section: Editorialmentioning

confidence: 99%

Wuhan novel coronavirus (COVID-19): why global control is challenging?

2020

View full text Add to dashboard Cite

Section: Editorialmentioning

confidence: 99%

Wuhan novel coronavirus (COVID-19): why global control is challenging?

2020

View full text Add to dashboard Cite

“…For example, the value of entry screening measures has been questioned, 9,10 while an evaluation of border entry screening measures in several countries concluded that a combination of communication methods (eg, in the form of pre-flight health information, in-flight videos, and clinical guidance) for passengers and clinicians might be a more effective strategy for global infectious disease control. 11 Collectively, the unique dynamics and interactions at play in an aircraft environment require a distinct response to infectious disease control.…”

Section: Introductionmentioning

confidence: 99%

Guidelines, law, and governance: disconnects in the global control of airline-associated infectious diseases

Grout

Howard

Coker

et al. 2017

The Lancet Infectious Diseases

View full text Add to dashboard Cite

International air travel is increasingly affecting the epidemiology of infectious diseases. A particular public health, economic, and political concern is the role of air travel in bringing infectious passengers or vectors to previously non-endemic areas. Yet, little research has been done to investigate either the infection risks associated with air travel or the empirical evidence for the effectiveness of infection control measures on aircraft and at borders. We briefly review the interface between international and national legislation, policy, and guidelines in the context of existing infection risks and possible scenarios. We have found that public health guidance and legislation, which airlines are required to follow, are often contradictory and confusing. Infection control measures for air travel need to be underpinned by coherent and enforceable national and international legislation that is based on solid epidemiological evidence. We recommend further research investment into more effective on-board vector control, health screening, and risk communications strategies, and the development of enforceable and harmonised international legislation.

show abstract

“…Upon arrival, travellers may be asymptomatic, either in the incubation period or have a subclinical infection, have mild symptoms, use antipyretics to reduce fever, or may not report their symptoms. Because cases may be missed, entry screening has been described as ineffective and resource-intensive (13,(20)(21)(22). However, the efficacy of border screening is difficult to evaluate (23).…”

Section: Discussionmentioning

confidence: 99%